|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/10 | |
| A61K 47/38 | |||
| A61P 1/00 | |||
| A61P 1/10 |
| (11) | Patento numeris | 2825188 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13713280.9 |
| Europos patento paraiškos padavimo data | 2013-03-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/030551 |
| Data | 2013-03-12 |
| (87) | Numeris | WO 2013/138352 |
| Data | 2013-09-19 |
| (30) | Numeris | Data | Šalis |
| 201213421769 | 2012-03-15 | US |
| (72) |
COMISKEY, Stephen, US
FENG, Rong, US
FOSS, John, US
SHAILUBHAI, Kunwar, US
|
| (73) |
Bausch Health Ireland Limited,
3013 Lake Drive Citywest Business Campus, Dublin 24,
IE
|
| (54) | FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE |
| FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE |